The main target of this study was to assess the circulating serum hypoxia biomarkers HIF-1α, VEGF, osteopontin, erythropoietin, caveolin-1, GLUT-1, and LDH pre- and post-radiotherapy in patients with brain tumors. This evidence concerns the gene EPO and brain neoplasm.